CHMP adopts a positive opinion for change to the marketing authorisation for zoonotic influenza vaccine Seqirus (Aflunov) – CSL
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the marketing authorisation for Zoonotic Influenza Vaccine Seqirus. The marketing authorisation… read more.
